Your browser doesn't support javascript.
loading
Consensus on collaborative ethical review of multi-center clinical trials of new drugs of traditional Chinese medicine (version 1.0) / 中国中药杂志
Article in Chinese | WPRIM | ID: wpr-879081
Responsible library: WPRO
ABSTRACT
At present, the issues regarding multi-center clinical trials of new drugs of traditional Chinese medicine(TCM) remain the lack of agreement on the content and scope of the ethical review among the ethics committee members of the center and the participating units results in repeated review, which leads to a time-consuming ethical review process. Moreover, the review capabilities of the ethics committees of various research centers are uneven, which is not necessarily beneficial to the protection of subjects' rights and safety. In view of the existing problems, to improve the efficiency of ethical review of multi-center clinical trials of new drugs of TCM and avoid repeated reviews, the TCM Clinical Evaluation Professional Committee of Chinese Pharmaceutical Association organized experts to formulate the "Consensus on collaborative ethical review of multi-center clinical trials of new drugs of TCM(version 1.0)"(hereinafter referred to as "Consensus"). The "Consensus" is formulated in accordance with the requirements of relevant documents such as but not limited to "the opinions on deepening the reform of the evaluation and approval system to encourage the innovation of pharmaceutical medical devices", "the regulations of ethical review of biomedical research involving human subjects". The "Consensus" covers the scope of application, formulation principles, conditions for the ethics committee of the center, sharing of ethical review resources, scope and procedure of collaborative review, rights and obligations, etc. The aims of the "Consensus" is to preliminarily explore and establish a scientific and operable ethical review procedure. Additionally, on the basis of fully protecting the rights and interests of the subjects, a collaborative ethical review agreement needs to be signed to clarify the ethical review responsibilities of all parties, to avoid repeated review, and to improve the efficiency and quality of ethical review in multi-center clinical trials of new drugs of TCM.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Humans / Drugs, Chinese Herbal / Pharmaceutical Preparations / Clinical Trials as Topic / Multicenter Studies as Topic / Ethical Review / Consensus / Biomedical Research / Medicine, Chinese Traditional Language: Chinese Journal: China Journal of Chinese Materia Medica Year: 2021 Type: Article
Full text: Available Index: WPRIM (Western Pacific) Main subject: Humans / Drugs, Chinese Herbal / Pharmaceutical Preparations / Clinical Trials as Topic / Multicenter Studies as Topic / Ethical Review / Consensus / Biomedical Research / Medicine, Chinese Traditional Language: Chinese Journal: China Journal of Chinese Materia Medica Year: 2021 Type: Article